share_log

東曜藥業(01875.HK)附屬獲Vivo Capital注資50萬美元

Dongyao Pharmaceutical (01875.HK) subsidiary received US $500000 injection from Vivo Capital

即市頭條 ·  Jan 9, 2022 04:36

Dongyao Pharmaceutical-B (01875.HK) announced that Vivo Capital Fund VIII has injected US $500000 into the company's subsidiary Exhibit. Upon completion, the registered capital of the exhibition will increase to US $2.85 million, with the company and Vivo Capital Fund VIII holding 82.46% and 17.54%, respectively.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment